KRAS and colorectal carcinoma: Four pathways were significantly up regulated in KRAS-mutant compared to that of KRAS wild-type CRC patients, namely, biosynthesis of amino acids, carbon metabolism, oxidative phosphorylation and ribosome (Fig. 1c).